Advertisement
PALM HARBOR, Fla., Dec. 6, 2017 /PRNewswire/ -- Dr. C. Randall Harrell, the Chief Medical Officer (CMO) of Regenerative Processing Plant (RPP), was recently the keynote speaker at the Veteran's Support Services Awards Gala on Veterans Day.
Dr. Harrell discussed burn pit inhalation injuries in active military and veterans, as well as his discovery of the First-in-Class next generation treatment: The PurAcel® Inhalation Solution, now available on DAPA.
PurAcel® Inhalation Solution is an option for active military and veterans who are suffering with lung damage due to various causes. A clinical trial, in conjunction with the Atlanta VA, is in early stages.
RPP's other innovative regenerative products are now available and listed on DAPA (therefore accessible to all active military and veterans) and include iRegen® and RegenaMax® Liquid and Tissue Allografts.
iRegen® is a self-administered eye treatment that may help with mild to severe dry eyes and may help some ocular injuries. It may be a superior substitute for the older technology of autologous tears as well as an advanced healing alternative to amniotic membrane. Patients no longer have to put up with time-consuming, painful procedures to solve their eye problems.
RegenaMax® Liquid Allograft can be administered through a 30-gauge needle. Other soft tissue and joint injuries can take a minimum of 3-12 months to see relief, RegenaMax's 3-phase treatment approach can have immediate relief potential and ongoing possible regenerative effects.
RegenaMax® Tissue Allograft is a wound management product that fosters healing of various injuries.
OF SIGNIFICANCE: All 4 products are acellular stem cell stimulators derived from RPP's patented technology. People who suffer from debilitating injuries or illness may be able to return to their regular lives and activities without surgical procedures. All four products have been shown to help with injuries that have been slow to heal or are unresponsive to other treatments.
About Dr. Harrell: Dr. Harrell is considered the Father of Regenerative Medicine. His patented, novel platform technologies such as Sterile D-MAPPS and other innovative products allow for a new standard of care for our active military and veterans, and others who suffer from chronic injuries and illnesses.
About Regenerative Processing Plant, LLC: RPP is a BioPharma company that is a pioneer in the rapidly growing field of Regenerative Medicine. Its visionary CMO is Dr. C. Randall Harrell, who invented and developed patent-protected and proprietary next generation platform technologies and a series of novel biologics for both the commercial market as well as the VA and DoD. These innovative products were designed to meet urgent needs in the fields of pulmonary, burns, wound care, pain, orthopedics, and ophthalmology.
If you would like more information about this topic, please contact our COO, Crissy Fellabaum, PhD, at (800) 781-0818 or email at [email protected].
Advertisement
Dr. Harrell discussed burn pit inhalation injuries in active military and veterans, as well as his discovery of the First-in-Class next generation treatment: The PurAcel® Inhalation Solution, now available on DAPA.
PurAcel® Inhalation Solution is an option for active military and veterans who are suffering with lung damage due to various causes. A clinical trial, in conjunction with the Atlanta VA, is in early stages.
RPP's other innovative regenerative products are now available and listed on DAPA (therefore accessible to all active military and veterans) and include iRegen® and RegenaMax® Liquid and Tissue Allografts.
iRegen® is a self-administered eye treatment that may help with mild to severe dry eyes and may help some ocular injuries. It may be a superior substitute for the older technology of autologous tears as well as an advanced healing alternative to amniotic membrane. Patients no longer have to put up with time-consuming, painful procedures to solve their eye problems.
RegenaMax® Liquid Allograft can be administered through a 30-gauge needle. Other soft tissue and joint injuries can take a minimum of 3-12 months to see relief, RegenaMax's 3-phase treatment approach can have immediate relief potential and ongoing possible regenerative effects.
RegenaMax® Tissue Allograft is a wound management product that fosters healing of various injuries.
OF SIGNIFICANCE: All 4 products are acellular stem cell stimulators derived from RPP's patented technology. People who suffer from debilitating injuries or illness may be able to return to their regular lives and activities without surgical procedures. All four products have been shown to help with injuries that have been slow to heal or are unresponsive to other treatments.
About Dr. Harrell: Dr. Harrell is considered the Father of Regenerative Medicine. His patented, novel platform technologies such as Sterile D-MAPPS and other innovative products allow for a new standard of care for our active military and veterans, and others who suffer from chronic injuries and illnesses.
About Regenerative Processing Plant, LLC: RPP is a BioPharma company that is a pioneer in the rapidly growing field of Regenerative Medicine. Its visionary CMO is Dr. C. Randall Harrell, who invented and developed patent-protected and proprietary next generation platform technologies and a series of novel biologics for both the commercial market as well as the VA and DoD. These innovative products were designed to meet urgent needs in the fields of pulmonary, burns, wound care, pain, orthopedics, and ophthalmology.
If you would like more information about this topic, please contact our COO, Crissy Fellabaum, PhD, at (800) 781-0818 or email at [email protected].
View original content:http://www.prnewswire.com/news-releases/rpp-announces-4-breakthrough-products-now-available-to-veterans-and-active-military-300567945.html
SOURCE Regenerative Processing Plant, LLC
